https://optimi.net/ 2026-04-22T01:08:39.861Z weekly 1 https://optimi.net/company 2026-04-22T01:08:39.861Z monthly 0.9 https://optimi.net/leadership 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/products 2026-04-22T01:08:39.861Z monthly 0.9 https://optimi.net/products/psilocybin-extract 2026-04-22T01:08:39.861Z monthly 0.7 https://optimi.net/products/mdma 2026-04-22T01:08:39.861Z monthly 0.7 https://optimi.net/manufacturing 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/global-access 2026-04-22T01:08:39.861Z weekly 0.9 https://optimi.net/knowledge 2026-04-22T01:08:39.861Z monthly 0.9 https://optimi.net/knowledge/psilocybin 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/knowledge/mdma 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/knowledge/gmp-manufacturing 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/knowledge/regulatory 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/knowledge/current-market 2026-04-22T01:08:39.861Z monthly 0.8 https://optimi.net/contact 2026-04-22T01:08:39.861Z yearly 0.5 https://optimi.net/privacy 2026-04-22T01:08:39.861Z yearly 0.3 https://optimi.net/cookies 2026-04-22T01:08:39.861Z yearly 0.3 https://optimi.net/terms 2026-04-22T01:08:39.861Z yearly 0.3 https://optimi.net/news 2026-04-22T01:08:39.861Z weekly 0.85 https://optimi.net/news/2026-04-launches-ibogaine-initiative-as-u-s-executive-order-signals 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-02-reports-early-clinical-rollout-of-natural-psilocybin-capsule 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-02-completes-psilocybin-export-to-australia-for-treatment-resis 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-02-reports-first-mdma-assisted-treatments-of-2026-are-underway 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-02-completes-mdma-export-for-ptsd-treatment-under-australia-s-a 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-01-completes-first-2026-production-of-mdma-and-psilocybin-capsu 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2026-01-to-present-at-the-sidoti-micro-cap-conference-on-january-21 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-12-announces-appointment-of-new-director 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-11-to-supply-mdma-to-maps-israel-s-clinical-trial-for-trauma-re 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-10-provides-corporate-update 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-10-s-psilocybin-capsules-selected-for-medibank-insurance-progra 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-09-optimi-announces-public-filing-of-registration-statement-for 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-09-announces-launch-of-psilocybin-capsules-in-australia-for-tre 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-08-provides-corporate-update 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-07-announces-3-45-million-convertible-financing-and-extension-o 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-05-completes-largest-to-date-mdma-export-to-australia-for-ptsd 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-05-obtains-u-s-fda-drug-establishment-registration 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-03-provides-corporate-update 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-01-completes-largest-mdma-capsule-batch-to-date-expands-stabili 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-01-provides-corporate-update 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-01-reports-first-patients-dosed-in-landmark-natural-psilocybin 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2025-01-completes-second-mdma-shipment-to-australia-and-expands-2025 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-12-to-supply-gmp-certified-psilocybin-for-psyence-biomed-s-phas 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-08-and-psyence-biomedical-sign-non-binding-letter-of-intent-to 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-06-awarded-drug-establishment-licence-from-health-canada 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-announces-closing-of-fully-subscribed-1-500-000-financing 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-secures-import-permit-from-mind-medicine-australia-for-mdma 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-atma-sign-letter-of-intent-to-advance-phase-ii-clinical-tria 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-receives-certificate-of-analysis-for-mdma-40mg-and-60mg-gmp 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-provides-corporate-update 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-05-receives-export-permit-from-health-canada-to-ship-mdma-to-te 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-04-and-kwantlen-polytechnic-university-applied-genomics-centre 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-04-signs-psilocybin-supply-agreement-with-new-zealand-based-māt 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-04-receives-finished-product-test-results-and-certificate-of-an 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-03-confirms-presenting-sponsorship-at-the-4th-annual-psychedeli 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-03-to-supply-mdma-for-psychedelic-research-at-tel-aviv-universi 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-02-optimi-announces-closing-of-first-tranche-of-non-brokered-pr 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-02-congratulates-lykos-therapeutics-on-fda-priority-review-of-n 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-02-optimi-announces-non-brokered-private-placement 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-02-to-host-mdma-educational-quality-assurance-webinar-for-clini 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-01-secures-amendment-to-increase-quantities-of-mdma-mda-and-2c 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2024-01-granted-precursor-licence-to-formulate-mdma-and-completes-en 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-12-and-sunshine-earth-labs-ltd-forge-strategic-supply-agreement 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-11-achieves-genetics-milestone-and-completes-psilocybin-extract 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-11-resolves-dispute 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-11-welcomes-dr-preston-a-chase-as-new-chief-science-officer 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-11-announces-third-and-final-tranche-of-cad-1-000-000-secured-f 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-09-celebrates-encouraging-results-from-the-maps-phase-3-mdma-as 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-09-granted-amendment-to-dealer-s-licence-by-health-canada-to-su 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-09-announces-second-tranche-of-cad-1-000-000-secured-for-debt-f 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-08-announces-cad-3-000-000-senior-debt-financing 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-08-optimi-completes-proprietary-natural-psilocybin-extraction-p 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-07-announces-receipt-of-purported-termination-notice 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-06-to-supply-mdma-for-therapist-experiential-training-program-a 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-05-completes-harvest-of-psilocybe-cubensis-for-delivery-to-the 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-05-granted-natural-health-product-site-licence-by-health-canada 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-05-announces-cad-1-2-million-gmp-psilocybin-supply-agreement-fo 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-03-enters-australian-medical-mdma-and-psilocybin-market-with-mi 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-02-submits-phase-i-clinical-trial-application-combining-the-use 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-02-completes-first-production-of-novel-mdma-drug-candidate-opti 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-01-expands-functional-mushroom-sales-network-with-additional-br 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2023-01-announces-re-appointments-to-board-of-directors 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-10-alberta-puts-patients-first-by-regulating-psychedelic-therap 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-09-atma-journey-centers-to-proceed-with-phase-i-natural-psilocy 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-09-completes-largest-legal-natural-psilocybin-harvest-in-canadi 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-09-signs-first-international-mushroom-supply-agreement-with-uk 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-09-provides-progress-report-on-year-of-commercialization 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-08-enters-into-international-collaborative-research-and-supply 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-08-announces-canadian-retail-and-e-commerce-distribution-agreem 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-08-health-canada-grants-mdma-production-and-distribution-amendm 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-08-unveils-canada-s-first-natural-therapeutic-psilocybin-produc 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-08-to-launch-therapeutic-psilocybin-product-in-partnership-with 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-07-finalizes-psilocybin-supply-agreement-with-bloom-psychedelic 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-06-initiates-agreement-with-sabi-mind-for-therapeutic-supplies 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-06-requests-approval-to-manufacture-mdma-other-synthetic-psyche 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-06-finalizes-partnership-and-psilocybin-supply-agreement-with-a 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-enters-into-psilocybin-supply-agreement-with-filament-health 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-signs-psilocybin-supply-agreement-with-halucenex-life-scienc 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-open-for-business-optimi-completes-first-grow-of-psilocybin 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-u-k-member-of-parliament-crispin-blunt-to-inaugurate-psilocy 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-acquires-extensive-catalog-of-psychedelic-and-functional-mus 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-completes-expansion-of-on-site-analytical-laboratory 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-applauds-health-canada-s-position-on-drug-quality-and-goods 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-05-granted-amendment-to-controlled-substances-dealer-s-licence 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-04-opens-canada-s-largest-gmp-grade-licensed-psilocybin-cultiva 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-03-begins-cultivation-of-natural-psilocybin-for-use-in-clinical 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-03-announces-investor-relations-agreement 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-03-upgrades-trading-to-the-otcqx-best-market 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-02-update---launches-e-commerce-platform-featuring-all-natural 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-02-launches-e-commerce-platform-featuring-all-natural-functiona 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-02-approved-to-supply-psilocybin-under-health-canada-s-special 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-02-dealer-s-license-granted-by-health-canada 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-01-submits-natural-psilocybin-combined-drug-delivery-and-extrac 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2022-01-provides-dealer-license-update-and-comments-on-health-canada 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-12-receives-dealers-license-inspection-and-introduces-quality-a 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-12-requests-final-inspection-for-dealer-s-license 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-11-engages-expert-management-consultancy-to-drive-corporate-vis 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-10-appoints-principal-investigator-for-clinical-dosing-study 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-10-natural-psilocybin-extraction-breakthrough-submitted-for-pro 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-09-updates-build-out-of-mushroom-production-and-research-facili 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-08-appoints-new-chief-executive-officer 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-08-updates-launch-of-online-functional-mushroom-sales 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-07-strengthens-clinical-and-regulatory-expertise 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-07-joins-first-psychedelic-exchange-traded-fund 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-07-initiates-pathway-to-nasdaq-listing 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-supports-patient-focused-psilocybin-advocacy-by-therapsil 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-engages-u-s-based-law-firm-for-patent-support 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-completes-otc-markets-uplisting-to-otcqb 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-completes-pre-clinical-trial-application-meeting 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-announces-product-distribution-agreement-with-vitasave 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-06-announces-dtc-eligibility-up-list-to-otcqb 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-05-appoints-chief-science-officer 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-05-and-numinus-wellness-submit-all-natural-psilocybin-extract-t 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-05-partnership-with-numinus-wellness-provides-update-on-first-a 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-04-finalizes-planned-build-out-of-mushroom-production-and-resea 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/2021-04-adds-to-corporate-and-advisory-team 2026-04-22T01:08:39.861Z yearly 0.6 https://optimi.net/news/page/2 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/3 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/4 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/5 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/6 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/7 2026-04-22T01:08:39.861Z weekly 0.7 https://optimi.net/news/page/8 2026-04-22T01:08:39.861Z weekly 0.7